Cargando…
Suppression of Frequent Ventricular Ectopy in a Patient with Hypertrophic Heart Disease with Ranolazine: A Case Report
BACKGROUND: Pro-arrhythmic concerns with most anti-arrhythmic agents in patients with significant left ventricular hypertrophy (LVH) limits options when anti-arrhythmic therapy is indicated. Ranolazine, an anti-anginal agent which inhibits late Na+ currents, indirectly causes a decrease in diastolic...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Indian Heart Rhythm Society
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3083144/ https://www.ncbi.nlm.nih.gov/pubmed/21556158 |